Postmenopausal hormone therapy: who now takes it and do they differ from non-users?

The Australian & New Zealand Journal of Obstetrics & Gynaecology
Anne W TaylorJodie C Avery

Abstract

Considerable changes in hormone therapy use have taken place in the last few years. To determine current usage of postmenopausal hormone therapy and assess the trend and rate of change in hormone therapy usage over the last 13 years. Additionally, to assess differences between current users and non-users for health-related and risk factor variables. Questions regarding hormone therapy use have been included in an annual face to face population health survey of South Australians eight times since 1991. In 2004, additional questions on health status and quality of life were included. In 2004, current use of hormone therapy was 15.4, 19.8 and 31.2% in all women over 40, 50 and 50-59 years, respectively. Ever use of hormone therapy among all women over 50 years was 46.5% with a mean duration of use of 7.46 years. Hormone therapy users did not differ from non-users in chronic disease indicators, body mass index, complementary medicine or therapist use, other health service use, socioeconomic status or quality of life. Increased hormone therapy use was associated with higher income, better educated, employed and married women in their sixth decade. Current use has varied over the years, with an increase to 2000, but a drop in 2003 an...Continue Reading

References

Sep 15, 1991·Annals of Internal Medicine·E Barrett-Connor
Nov 1, 1990·American Journal of Obstetrics and Gynecology·J A CauleyD G Seeley
Apr 17, 1995·The Medical Journal of Australia·A H MacLennanD H Wilson
May 1, 1993·Maturitas·A H MacLennanD Wilson
Aug 15, 1996·The New England Journal of Medicine·F GrodsteinC H Hennekens
Apr 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B R Carr
Aug 10, 1996·BMJ : British Medical Journal·P Toozs-Hobson, L Cardozo
Aug 10, 1996·BMJ : British Medical Journal·H S Jacobs
May 23, 1998·Clinical Cardiology·J Abrams
Sep 22, 2000·BMJ : British Medical Journal·G HawthorneR T Lie
Dec 22, 2000·Spine·J E Ware
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·A H MacLennanD Wilson
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·D O'ConnellW Gillespie
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·A H MacLennanA W Taylor
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·D H WilsonA H MacLennan
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Dec 7, 2002·International Journal of Cardiology·Kwang Kon Koh
Mar 19, 2003·The New England Journal of Medicine·Jennifer HaysUNKNOWN Women's Health Initiative Investigators
Aug 9, 2003·The New England Journal of Medicine·JoAnn E MansonUNKNOWN Women's Health Initiative Investigators
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Adam L HershRandall S Stafford
Jul 6, 2004·Australian and New Zealand Journal of Public Health·Jodie C AveryAnne W Taylor
Jul 21, 2004·Climacteric : the Journal of the International Menopause Society·A WeltonUNKNOWN Women's International Study of long Duration Oestrogen after Menopause (WISDOM) team
Aug 11, 2004·Archives of Internal Medicine·Nananda F ColPhaedra Corso
Sep 10, 2004·Menopause : the Journal of the North American Menopause Society·Renee M BrennanJean Wactawski-Wende
Oct 23, 2004·Climacteric : the Journal of the International Menopause Society·A H MacLennanD H Wilson
Aug 23, 2005·Climacteric : the Journal of the International Menopause Society·H Kuhl
Jan 5, 2006·Climacteric : the Journal of the International Menopause Society·Shelley Salpeter
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Alastair H MacLennanAnne W Taylor

❮ Previous
Next ❯

Citations

May 8, 2013·Cancer Causes & Control : CCC·Kerri R BeckmannJohn W Lynch
Apr 22, 2010·Family Practice·Alm Lagro-JanssenC van Weel
Dec 18, 2007·American Journal of Preventive Medicine·Mary K CanalesRachel R Ballard-Barbash
Oct 30, 2007·Maturitas·Rachel E WilliamsRichard V Clark
Mar 26, 2010·Pharmacoepidemiology and Drug Safety·Sandra A NormanMarion R Nadel
Feb 20, 2015·Journal of Clinical and Experimental Neuropsychology·Nathalie CastonguayLouis Bherer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Jacques E RossouwWriting Group for the Women's Health Initiative Investigators
Pharmacoepidemiology and Drug Safety
Judith Parsells KellyAllen A Mitchell
The Australian & New Zealand Journal of Obstetrics & Gynaecology
Catherine TraversRobert King
© 2022 Meta ULC. All rights reserved